Franz Kiel GmbH, headquartered in Nördingen, Germany, is to use Si-Quat, an anti-microbial coating effective against the virus that causes Covid-19, is seating for the global transportation industry.

Produced by Affix-Labs, of Helsinki, Finland, Si-Quat anti-microbial surface coating is being deployed to protect public transport interiors from contagious microbes such as the Sars-Cov-2 virus.

Millions of people rely on public transport infrastructure every day and it will be crucial to the opening of economies after Covid-19 lockdowns around the world. Yet many viruses and bacteria, including the Sars-Cov-2, can survive for up to three days on some surfaces, meaning regularly touched areas in public spaces have the potential to be cross contamination hotspots.

Si-Quat will now be helping to make public transport safer as people around the world begin getting back onto buses and trains.

The product has a durable layer of polymerized active ingredient that binds to walls, handles, furniture, and other key touch points, staying in place for up to 12 months and killing 99.9% of viruses and bacteria coming into contact with the treated surface. The coating has been tested and certified to be effective against bacteria, viruses, and fungi, and has passed the rigorous EN45545-2 HL3 flammability norm for trains and REG118.3 for busses.

Kiel has been manufacturing high quality seating for public transport globally for more than 75 years and with Si-Quat already registered on several continents, a quick roll out is achievable.

“We are delighted to be working with Affix Labs to roll out Si-Quat in public transport systems around the world,” said Kiel sales director Daniel Fräde. “It’s easy to apply, it works, and we have had great support from the Affix-Labs team. We hope that our partnership can help to re-open countries and boost passenger trust in once again using public transport.”

www.affixlabs.com